ATE177641T1 - Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung - Google Patents

Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung

Info

Publication number
ATE177641T1
ATE177641T1 AT93911478T AT93911478T ATE177641T1 AT E177641 T1 ATE177641 T1 AT E177641T1 AT 93911478 T AT93911478 T AT 93911478T AT 93911478 T AT93911478 T AT 93911478T AT E177641 T1 ATE177641 T1 AT E177641T1
Authority
AT
Austria
Prior art keywords
hyaluronic acid
pct
molecular weight
low molecular
bone formation
Prior art date
Application number
AT93911478T
Other languages
English (en)
Inventor
Lanfranco Callegaro
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE177641T1 publication Critical patent/ATE177641T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
AT93911478T 1992-04-17 1993-04-16 Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung ATE177641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920071A IT1260148B (it) 1992-04-17 1992-04-17 Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo

Publications (1)

Publication Number Publication Date
ATE177641T1 true ATE177641T1 (de) 1999-04-15

Family

ID=11389901

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911478T ATE177641T1 (de) 1992-04-17 1993-04-16 Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung

Country Status (11)

Country Link
US (1) US5646129A (de)
EP (1) EP0637245B1 (de)
JP (1) JP3333205B2 (de)
KR (1) KR100310277B1 (de)
AT (1) ATE177641T1 (de)
AU (1) AU677189B2 (de)
CA (1) CA2118219C (de)
DE (1) DE69324006T2 (de)
ES (1) ES2130268T3 (de)
IT (1) IT1260148B (de)
WO (1) WO1993020827A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001181A1 (en) * 1993-07-01 1995-01-12 Allelix Biopharmaceuticals Inc. Hyaluronic acid fragments and their therapeutic use
IT1282219B1 (it) * 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
US6875753B1 (en) 1996-03-14 2005-04-05 The Governors Of The University Of Alberta Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US20050101564A1 (en) * 1996-04-02 2005-05-12 Pilarski Linda M. Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
US6872819B1 (en) 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
JP3032824B1 (ja) * 1999-01-28 2000-04-17 東京医科歯科大学長 骨誘導促進剤
ES2242600T3 (es) * 1999-02-04 2005-11-16 Sdgi Holdings, Inc. Composiciones de pasta osteogenica y sus usos.
IT1306644B1 (it) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6576226B1 (en) 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
JP2004250592A (ja) * 2003-02-20 2004-09-09 Seikagaku Kogyo Co Ltd 紫外線照射による低分子化グリコサミノグリカンの製造方法
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US20060183709A1 (en) * 2005-02-15 2006-08-17 Ahmad Alkayali Preparation of low molecular weight hyaluronic acid as a food supplement
US20100075921A1 (en) * 2005-02-15 2010-03-25 Ahmad Alkayali Prêparation of hyaluronic acid with desired low molecular weight as a food supplement
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
BRPI0621470A2 (pt) 2006-12-05 2011-12-13 Glycoscience Lab Inc agente terapêutico para artrite degenerativa
US8529951B1 (en) 2007-02-21 2013-09-10 Anand Ramamurthi Elastogenic cues and methods for using same
FR2919185B1 (fr) * 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
WO2013123791A1 (zh) 2012-02-21 2013-08-29 华熙福瑞达生物医药有限公司 一种芽孢杆菌、一种透明质酸酶、以及其用途
MX2018012486A (es) * 2016-04-12 2019-06-06 Illustris Pharmaceuticals Inc Composiciones para aplicacion topica de compuestos.
JP2018168263A (ja) * 2017-03-29 2018-11-01 日油株式会社 植物性プロテオグリカン及びその用途
CA3078631A1 (en) * 2017-10-11 2019-04-18 Jacob M. Waugh Methods and compositions for topical delivery
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3482812D1 (de) * 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
JP2604135B2 (ja) * 1986-02-28 1997-04-30 ライオン株式会社 口腔骨疾患治療剤
US5041138A (en) * 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
GB2215209B (en) * 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
JPH01265970A (ja) * 1988-04-19 1989-10-24 Shiseido Co Ltd ヒアルロン酸を含有させたコラーゲン水溶液又は水分散液
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
SE501217C2 (sv) * 1990-12-06 1994-12-12 Skandigen Ab Cellproliferationsmatris och användning därav

Also Published As

Publication number Publication date
ITPD920071A0 (it) 1992-04-17
EP0637245B1 (de) 1999-03-17
CA2118219C (en) 2004-06-01
KR100310277B1 (ko) 2001-12-28
ITPD920071A1 (it) 1993-10-17
DE69324006D1 (de) 1999-04-22
ES2130268T3 (es) 1999-07-01
DE69324006T2 (de) 1999-11-11
AU4040493A (en) 1993-11-18
JP3333205B2 (ja) 2002-10-15
JPH08508973A (ja) 1996-09-24
AU677189B2 (en) 1997-04-17
EP0637245A1 (de) 1995-02-08
CA2118219A1 (en) 1993-10-28
WO1993020827A1 (en) 1993-10-28
IT1260148B (it) 1996-03-28
US5646129A (en) 1997-07-08

Similar Documents

Publication Publication Date Title
ATE177641T1 (de) Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung
DE69520364D1 (de) Benzothepines mit wirkung als inhibitoren des gallensäuretransports und der taurocholate-aufnahme
MX9203050A (es) Compuestos de analogos de triptamina.
EA200200806A1 (ru) Предупреждение потери и восстановление костной массы некоторыми агонистами простагландина
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ATE192045T1 (de) Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
BR9205640A (pt) Dímero de apolipoproteína ai-milano, composiçao farmacológica, processo de preparaçao do dímero, uso deste na preparaçao de medicamentos e processo para o tratamento de aterosclerose e doenças cardiovasculares
EP1007556A4 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
CA2265508A1 (en) Bone morphogenetic protein-16 (bmp-16) compositions
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
ATE250422T1 (de) Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
RU95105983A (ru) Ингибиторы тромбина, способы их получения и фармацевтическая композиция на их основе
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
GB9116056D0 (en) Compounds
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
EA199700451A1 (ru) Мономерные 4,4-(дизамещенные) циклогексан-1-олы и родственные соединения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name